The global female infertility market is experiencing steady growth, driven by increasing awareness, changing lifestyle factors, and rising health conditions linked to infertility. According to the latest report from The Business Research Company, the market size is expected to rise from $1.79 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%. Looking further ahead, the market is projected to reach $2.19 billion by 2029, growing at a CAGR of 4.1%.
Key Drivers of Market Growth
Several factors are contributing to the increase in infertility rates, which is directly impacting the demand for female infertility treatments. Notable drivers include delayed childbearing, evolving lifestyle choices, environmental toxins, rising obesity rates, and higher stress levels. Additionally, medical conditions such as polycystic ovary syndrome (PCOS), uterine abnormalities, genetic disorders, and obesity are on the rise, further elevating the need for effective fertility treatments.
In 2022, licensed fertility clinics in the UK performed nearly 77,000 fresh and frozen embryo transfer cycles for approximately 52,500 patients, according to the Human Fertilization and Embryology Authority. This increasing demand highlights the growing recognition of infertility issues and the need for timely medical interventions.
Emerging Trends in Female Infertility Treatment
Advancements in the field of fertility treatment are driving innovation. Significant progress has been made in preimplantation genetic testing, novel diagnostic technologies, fertility preservation, and telemedicine. Companies are increasingly focusing on non-invasive diagnostic methods. For example, Heranova Lifesciences, a US-based biotech firm, recently launched a non-invasive diagnostic test, HerResolve, designed to detect endometriosis—a major contributor to infertility in women.
Other innovations in the sector include improved techniques for IVF cycles, advanced hormonal treatments, and the growing use of fertility preservation methods such as egg freezing. These developments are making treatments more accessible and less invasive for women seeking to preserve their fertility or address underlying issues.
Key Players in the Market
Prominent companies driving the female infertility market include major pharmaceutical and healthcare players such as Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, and Teva Pharmaceutical Industries Ltd. These companies are at the forefront of developing new treatments, therapies, and technologies to improve the chances of conception for women facing infertility challenges.
Market Segmentation
The female infertility market is segmented by various factors, including types of treatments, routes of administration, and end-users. Treatment options range from Clomiphene Citrate and Gonadotropins to Metformin, Letrozole, and Bromocriptine. The routes of administration include oral, parenteral, and other forms of treatment delivery. End-users in the market include hospital pharmacies, retail pharmacies, and online pharmacies, catering to different consumer needs and preferences.
Regional Insights
Europe was the largest market for female infertility treatments in 2024. However, the Asia-Pacific region is expected to be the fastest-growing market, driven by increasing awareness, improving healthcare infrastructure, and a rising number of infertility cases. Other regions covered in the report include North America, South America, the Middle East, and Africa.
Looking Ahead
With the global female infertility market set to expand steadily in the coming years, innovative treatments, better access to care, and technological advancements will play a significant role in addressing the growing demand. The increasing recognition of infertility as a medical issue and the ongoing development of new treatment options provide promising prospects for women seeking reproductive health solutions.
For more detailed market analysis and insights, the full report is available for purchase, offering an in-depth look at the current trends, key players, and future projections in the female infertility sector.
Related topics:
